-
Spinraza May Slow SMA Progression in Pre-symptomatic Infants
Biogen’s Spinraza (nusinersen) retards disease progression in pre-symptomatic SMA infants, according to updated results of a Phase 2 clinical study. Read more about this here.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.